CGTX · Cognition Therapeutics Inc
$1.01
-0.03 (-2.88%)
At close · Aug 14
Market Cap
$96.04M
Shares
95.09M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.01
Open$1.04
Day$1.00–1.05
52W close$0.60–3.18
Avg vol 30d940K
Short int8.9M · 9.4% float · 21.1d
Short vol65%
Last earningsMar 26, 2026
DataOct 2021–Aug 2026
Filing10-Q · Aug 7
Up next
Next earnings call
Aug 31, 2026
Est · unconfirmed
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 7, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−18%
below
Price vs 50-day avg
−8%
below
RSI (14)
48
neutral
MACD trend
Positive
52-week position
16%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+5%
trailing
6-month return
−3%
trailing
YTD return
−25%
this year
Relative strength
−17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-12% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.39% of float · ▼ -7.7% MoM · 21.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
66 holders — mid 3-yr range
Squeeze score
60
elevated · 0–100
Fundamentals
EPS growth
+63%
Y/Y
Free cash flow
$-24.6M
Balance sheet
$36.8M
net cash
Quant / Vol
risk profile
Volatility
119%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
7.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−18%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
48
Neutral
MACD trend
Positive
Bullish
52-week position
16%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-12% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
9.39% of float · ▼ -7.7% MoM · 21.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
66 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 16%
Range high $3
vs 200-day avg -18%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CGTX
this stock
Cognition Therapeutics Inc
|
$96.04M | -25.2% | — | — | 9.4% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CGTX | -6.5% | +5.1% | -2.9% | +13.5% | -25.2% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -6.9% | +0.7% | -16.7% | +9.6% | -39.0% |
Key facts
CIK
1455365
CUSIP
19243B102
13F (30d)
60 filings
60 filers
Visit website
Investor relations